99 results
S-3ASR
SLNO
Soleno Therapeutics Inc
2 Jan 24
Automatic shelf registration
4:06pm
contract, and the nature and amount of each of those securities, or the method of determining those amounts;
whether the purchase contracts
S-3ASR
EX-4.3
SLNO
Soleno Therapeutics Inc
2 Jan 24
Automatic shelf registration
4:06pm
:
(a) a statement that the person making such certificate or opinion has read such covenant or condition;
(b) a brief statement as to the nature and scope
D
g7hwm7 yoaqao132bdx
4 Oct 23
$59.99 mm in equity / options / securities to be acquired, sold $59.99 mm, 14 investors
10:36am
8-K
EX-10.1
xj5n1b3qm6 fcdwe2
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.1
t4x1lw178 ols
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-1.2
1a83darvohhsly4qu 1k
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
0jdt4b09lavv2cfak
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
vjf307
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.1
kgw1u ka38
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.3
36fu6dl
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.2
c84p369y1 y3c
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm